Milan Dejmek

1.1k citations

48 papers · 797 indexed · h-index 17

Co-authors: Radim Nencka Michal Šála Hubert Hřebabecký Evžen Bouřa Martin Dračínský Christina Schneider Sidney Becker Hidenori Okamura
Topics: interferon and immune responses (13 papers)Biochemical and Molecular Research (8 papers)Mosquito-borne diseases and control (7 papers)
Cited by: Physiology Infectious Diseases Immunology
Journals: Nucleic Acids Research Angewandte Chemie International Edition Nature Communications
Partner nations: Czechia Belgium United States

In The Last Decade

Milan Dejmek

47 papers receiving 789 citations

Peers

Countries citing papers authored by Milan Dejmek

Since Specialization

Citations

This map shows the geographic impact of Milan Dejmek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milan Dejmek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milan Dejmek more than expected).

Fields of papers citing papers by Milan Dejmek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milan Dejmek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milan Dejmek. The network helps show where Milan Dejmek may publish in the future.

Co-authorship network of co-authors of Milan Dejmek

This figure shows the co-authorship network connecting the top 25 collaborators of Milan Dejmek. A scholar is included among the top collaborators of Milan Dejmek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milan Dejmek. Milan Dejmek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5′-carboxamides 2024 ·RSC Medicinal Chemistry ·(unknown),Dominika Chalupská,Milan Dejmek,(unknown),(unknown),Michal Šála,Karel Chalupský,Petra Krafčíková,(unknown),(unknown),Eliška Procházková,Blanka Klepetářová,(unknown),(unknown),Helena Mertlíková‐Kaiserová,Evžen Bouřa,Jan Weber,Radim Nencka	5
2	Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics 2024 ·Beilstein Journal of Organic Chemistry ·(unknown),(unknown),Milan Dejmek,(unknown),Blanka Klepetářová,Lenka Poštová Slavětínská,Evžen Bouřa,Radim Nencka	3
3	Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy 2023 ·European Journal of Medicinal Chemistry ·Milan Dejmek,Andrea Brázdová,(unknown),(unknown),Martin Klíma,(unknown),(unknown),Miloš Buděšı́nský,Martin Dračínský,Radek Liboska,Evžen Bouřa,(unknown),Radim Nencka	8
4	Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping 2023 ·Journal of Medicinal Chemistry ·(unknown),Eva Řezníčková,(unknown),Radek Jorda,Milan Dejmek,(unknown),Michal Šála,(unknown),Martin Dračínský,(unknown),(unknown),(unknown),Karel Chalupský,(unknown),Tomáš Gucký,Helena Mertlíková‐Kaiserová,Pavel Klener,Radim Nencka,Vladimı́r Kryštof	8
5	Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNF 2023 ·Nucleic Acids Research ·Kateřina Čermáková,Ling Tao,Milan Dejmek,Michal Šála,(unknown),Yuen San Chan,(unknown),(unknown),(unknown),(unknown),Ronald J. Parchem,Wenyi Wang,Radim Nencka,Eveline Barbieri,H. Courtney Hodges	5
6	Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors 2023 ·ACS Omega ·(unknown),Dominika Chalupská,Karel Chalupský,(unknown),(unknown),Petra Krafčíková,(unknown),Michal Šála,Milan Dejmek,(unknown),(unknown),Jaroslav Kozák,(unknown),Masoud Vedadi,Jan Weber,Helena Mertlíková‐Kaiserová,Radim Nencka	13
7	SWI/SNF Blockade Disrupts PU.1-Directed Enhancer Programs in Normal Hematopoietic Cells and Acute Myeloid Leukemia 2023 ·Cancer Research ·(unknown),Kateřina Čermáková,Yuen San Chan,(unknown),(unknown),(unknown),(unknown),(unknown),Milan Dejmek,Michal Šála,(unknown),(unknown),Radim Nencka,H. Daniel Lacorazza,Rachel E. Rau,H. Courtney Hodges	21
8	Exploring positions 6 and 7 of a quinazoline-based scaffold leads to changes in selectivity and potency towards RIPK2/3 kinases 2023 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),Kamil Hercík,(unknown),Dominika Chalupská,Milan Dejmek,Michal Šála,Miroslav Hájek,Evžen Bouřa,Helena Mertlíková‐Kaiserová,Radim Nencka	1
9	Structure-based design and modular synthesis of novel PI4K class II inhibitors bearing a 4-aminoquinazoline scaffold 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Martin Klíma,(unknown),Dominika Chalupská,Milan Dejmek,Michal Šála,Helena Mertlíková‐Kaiserová,Evžen Bouřa,Radim Nencka	5
10	Synthetic Stimulator of Interferon Genes (STING) Agonists Induce a Cytokine-Mediated Anti-Hepatitis B Virus Response in Nonparenchymal Liver Cells 2022 ·ACS Infectious Diseases ·(unknown),(unknown),(unknown),Milan Dejmek,(unknown),(unknown),Andrea Brázdová	13
11	Design, Synthesis, and Biochemical and Biological Evaluation of Novel 7-Deazapurine Cyclic Dinucleotide Analogues as STING Receptor Agonists 2022 ·Journal of Medicinal Chemistry ·(unknown),Pavla Perlíková,(unknown),(unknown),(unknown),(unknown),Milan Dejmek,(unknown),Miloš Buděšı́nský,Radek Liboska,(unknown),J. Brynda,Evžen Bouřa,Pavlína Řezáčová,Michal Hocek,(unknown)	18
12	Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein 2021 ·Angewandte Chemie ·(unknown),Ondrej Gutten,Milan Dejmek,Milan Kožíšek,Thomas Evangelidis,Zahra Aliakbar Tehrani,(unknown),Radim Nencka,(unknown),Lubomı́r Rulı́šek,Evžen Bouřa	2
13	Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein 2021 ·Angewandte Chemie International Edition ·(unknown),Ondrej Gutten,Milan Dejmek,Milan Kožíšek,Thomas Evangelidis,Zahra Aliakbar Tehrani,(unknown),Radim Nencka,(unknown),Lubomı́r Rulı́šek,Evžen Bouřa	28
14	Non-Nucleotide RNA-Dependent RNA Polymerase Inhibitor That Blocks SARS-CoV-2 Replication 2021 ·Viruses ·Milan Dejmek,Eva Konkoľová,Luděk Eyer,Petra Straková,Pavel Svoboda,Michal Šála,(unknown),Daniel Růžek,Evžen Bouřa,Radim Nencka	27
15	Synthesis and Biological Evaluation of Phosphoester and Phosphorothioate Prodrugs of STING Agonist 3′,3′-c-Di(2′F,2′dAMP) 2021 ·Journal of Medicinal Chemistry ·(unknown),(unknown),Martin Kaiser,(unknown),Martin Dračínský,(unknown),Aleš Marek,Milan Dejmek,Michal Šála,Ondrej Gutten,Lubomı́r Rulı́šek,(unknown),Andrea Brázdová,Zlatko Janeba,Radim Nencka,Evžen Bouřa,Ondřej Páv,(unknown)	32
16	Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses 2020 ·Antiviral Research ·Eva Konkoľová,Milan Dejmek,Hubert Hřebabecký,Michal Šála,(unknown),Radim Nencka,Evžen Bouřa	48
17	Synthesis and anti-human immunodeficiency virus activity of substituted (o,o-difluorophenyl)-linked-pyrimidines as potent non‐nucleoside reverse transcriptase inhibitors 2019 ·Antiviral chemistry & chemotherapy ·(unknown),Milan Dejmek,Ondřej Baszczyňski,David Šaman,(unknown),Eric Hu,George Stepan,Petr Jansa,Zlatko Janeba,Petr Šimon	6
18	Wet-dry cycles enable the parallel origin of canonical and non-canonical nucleosides by continuous synthesis 2018 ·Nature Communications ·Sidney Becker,Christina Schneider,Hidenori Okamura,Antony L. Crisp,Tynchtyk Amatov,Milan Dejmek,Thomas Carell	105
19	The high-resolution crystal structure of phosphatidylinositol 4-kinase IIβ and the crystal structure of phosphatidylinositol 4-kinase IIα containing a nucleoside analogue provide a structural basis for isoform-specific inhibitor design 2015 ·Acta Crystallographica Section D Biological Crystallography ·Martin Klíma,(unknown),Dominika Chalupská,Hubert Hřebabecký,Milan Dejmek,Radim Nencka,Evžen Bouřa	22
20	Novel substituted 9-norbornylpurines and their activities against RNA viruses 2012 ·Bioorganic & Medicinal Chemistry Letters ·Michal Šála,Hubert Hřebabecký,Pieter Leyssen,Milan Dejmek,Martin Dračínský,(unknown),Johan Neyts,Radim Nencka	7

About Milan Dejmek

Milan Dejmek is a scholar working on Physiology, Infectious Diseases and Immunology, having authored 48 papers that have together received 797 indexed citations. Recurring topics across this work include interferon and immune responses (13 papers), Biochemical and Molecular Research (8 papers) and Mosquito-borne diseases and control (7 papers). The work is most often cited by research in Physiology (62 citations), Infectious Diseases (225 citations) and Immunology (200 citations). Milan Dejmek has collaborated with scholars based in Czechia, Belgium and United States. Frequent co-authors include Radim Nencka, Michal Šála, Hubert Hřebabecký, Evžen Bouřa, Martin Dračínský, Christina Schneider, Sidney Becker, Hidenori Okamura, Thomas Carell and Antony L. Crisp. Their work appears in journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact